(Q30477320)

30 September 2017

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report (English)

1 reference

30 September 2017

0 references

arterial hypertension

1 reference

5

S Oparil

1 reference

30 September 2017

K Gaddam

1

1 reference

30 September 2017

E Pimenta

2

1 reference

30 September 2017

S J Thomas

3

1 reference

30 September 2017

S S Cofield

4

1 reference

30 September 2017

S M Harding

6

1 reference

30 September 2017

D A Calhoun

7

1 reference

30 September 2017

17 December 2009

1 reference

Journal of Human Hypertension

30 September 2017

1 reference

30 September 2017

24

1 reference

30 September 2017

8

1 reference

30 September 2017

532-537

1 reference

Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Sleep apnea and hypertension: interactions and implications for management.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Obstructive sleep apnea as a risk factor for stroke and death

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2891919

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

20 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Diuretics in obstructive sleep apnea with diastolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Primary aldosteronism and hypertensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2009.96

21 January 2018

Identifiers

DOI

10.1038/JHH.2009.96

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference

30 September 2017

PubMed publication ID

20016520

1 reference